Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02627443
Title Carboplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 United States Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
UCHealth University of Colorado Hospital Aurora Colorado 80045 United States Details
University of Florida Health Science Center - Gainesville Gainesville Florida 32610 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from for the field